2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Choriocarcinoma: new trials by email Literature Review of Choriocarcinoma trials Research Report on Choriocarcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| TRC105 Combined With Standard-dose Bevacizumab for Two Patients With Metastatic And Refractory Choriocarcinoma TRC105, Bevacizumab - Choriocarcinoma | Phase 2 | Completed | Tracon Pharmaceuticals Inc. | 2 | 2015-01-01 | 2019-06-11 |
| A Trial for Patients With Gestational Trophoblastic Disease Pemetrexed - Trophoblastic Neoplasms, Uterine Neoplasms | Phase 2 | Completed | Eli Lilly and Company | 50 | 2006-07-01 | 2007-08-09 |
Hydatidiform Mole (1) · Trophoblastic Neoplasms (1) · Uterine Neoplasms (1)
Adenocarcinoma (2) · Carcinoma (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Germ Cell and Embryonal (2) · Neoplasms, Glandular and Epithelial (2) · Pregnancy Complications (2) · Pregnancy Complications, Neoplastic (2) · Urogenital Diseases (2) · Female Urogenital Diseases (1) · Genital Diseases (1) · Genital Diseases, Female (1) · Genital Neoplasms, Female (1) · Gestational Trophoblastic Disease (1)
Bevacizumab (1) · Pemetrexed (1) · carotuximab (1)
Eli Lilly and Company (1) · Tracon Pharmaceuticals Inc. (1)
United States (2)
Charles Theuer, MD (1) · David Miller, MD (1)